Article Details
Retrieved on: 2022-07-15 02:37:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SK Biopharm researchers South Korea's SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic ...
Article found on: www.kedglobal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here